FDA Inspection 682984 — Abon Biopharm (Hangzhou) Co., Ltd.
The FDA completed an inspection of Abon Biopharm (Hangzhou) Co., Ltd. on Sep 21, 2010 in Hangzhou. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Devices.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Sep 21, 2010
- Fiscal Year
- 2010
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Hangzhou (China)